Guidelines for diagnostics and treatment of aromatase inhibitor-induced bone loss in women with breast cancer A consensus of Lithuanian medical oncologists, radiation oncologists, endocrinologists, and family medicine physicians
Abstract
Share and Cite
Juozaitytė, E.; Aleknavičius, E.; Jančiauskienė, R.; Česas, A.; Pipirienė-Želvienė, T.; Liutkauskienė, S.; Krasauskienė, A.; Vencevičienė, L. Guidelines for diagnostics and treatment of aromatase inhibitor-induced bone loss in women with breast cancer A consensus of Lithuanian medical oncologists, radiation oncologists, endocrinologists, and family medicine physicians. Medicina 2014, 50, 197-203. https://doi.org/10.1016/j.medici.2014.09.004
Juozaitytė E, Aleknavičius E, Jančiauskienė R, Česas A, Pipirienė-Želvienė T, Liutkauskienė S, Krasauskienė A, Vencevičienė L. Guidelines for diagnostics and treatment of aromatase inhibitor-induced bone loss in women with breast cancer A consensus of Lithuanian medical oncologists, radiation oncologists, endocrinologists, and family medicine physicians. Medicina. 2014; 50(4):197-203. https://doi.org/10.1016/j.medici.2014.09.004
Chicago/Turabian StyleJuozaitytė, Elona, Eduardas Aleknavičius, Rasa Jančiauskienė, Alvydas Česas, Teresė Pipirienė-Želvienė, Sigita Liutkauskienė, Aurelija Krasauskienė, and Lina Vencevičienė. 2014. "Guidelines for diagnostics and treatment of aromatase inhibitor-induced bone loss in women with breast cancer A consensus of Lithuanian medical oncologists, radiation oncologists, endocrinologists, and family medicine physicians" Medicina 50, no. 4: 197-203. https://doi.org/10.1016/j.medici.2014.09.004